Causes of Prostate Cancer: 6 Things You Should Know
Here are six things you should know about the possibility of developing prostate cancer. Read the article.
Causes of Prostate Cancer: 6 Things You Should Know Read More »
Side Effects of Radiation Therapy May Be Eased by a Diet Rich in Tomatoes, Study Reports
Researchers in the U.K. and Germany report that lycopene, a carotenoid pigment present in tomatoes, can protect human lymphoid cells against the harmful effects of gamma radiation during radiation therapy, a common treatment for cancer, and could be used as a dietary intervention. Read the article.
Side Effects of Radiation Therapy May Be Eased by a Diet Rich in Tomatoes, Study Reports Read More »
Nutrition, aging and cancer: lessons from dietary intervention studies
Mediterranean diet has been reported to significantly reduce mortality rates for various chronic illnesses, including cardiovascular diseases, neurodegenerative diseases and cancer. Although many observational studies have supported this evidence, dietary intervention studies using a Mediterranean dietary pattern or its selected food components are still limited and affected by a rather large variability in characteristics of study subjects, type and length of intervention, selected end-points and statistical analysis. Read the article.
Nutrition, aging and cancer: lessons from dietary intervention studies Read More »
Newsletter July 2016
Awareness: The PCCN-Toronto and Side by Side Prostate Cancer Support Groups Newsletter. In this Issue: May Awareness Night: Dr. Rajiv Singal, Twenty years of caring for men with prostate cancer March Awareness Night: Justin Lorentz (w. Dr. Danny Vesprini), Who is genetically predisposed Coming July Awareness Night: Dr. Masoom Haider, MRI of the prostate: A revolution in diagnosis and treatment Jim Moran (1942-2016) Do It For Dads Walk/Run – Father’s Day 2016 with photos Ask the Doctor – Our 3 doctors answer 2 questions Board News Welcome Ari Katz Information meeting – Sept. 27 – conference feedback, volunteer news Meet
Newsletter July 2016 Read More »
Markers redefining prostate cancer care
The discovery of new prostate cancer biomarkers has led to a number of tests that have begun to alter the diagnosis and management of the disease. Read the article.
Markers redefining prostate cancer care Read More »
Cholesterol drug may fight prostate cancer, scientists say
A drug designed to lower cholesterol stops the progression of prostate cancer, according to researchers at the University of Missouri. Read the article.
Cholesterol drug may fight prostate cancer, scientists say Read More »
Cancer Therapy: An Evolved Approach
Tumours are subject to the same rules of natural selection as any other living thing. Clinicians are now putting that knowledge to use. Thanks to advances in sequencing technology and the development of massive collections of samples and clinical data, scientists are piecing together a more precise picture of how cancer evolves, revealing the roots of resistance and, in some cases, finding out how it might be overcome. With a growing arsenal of treatments, biologists are trying to capitalize on these insights. Read the article.
Cancer Therapy: An Evolved Approach Read More »
More than 3 percent of men on active surveillance for prostate cancer may have metastases
Investigators at the Sunnybrook Health Sciences Centre, University of Toronto initiated a study to assess the risk factors for metastases in patients on active surveillance. About three percent of patients on surveillance had metastasis by a median of seven years after diagnosis. This risk increased to ten percent in patients with Gleason score (GS) 7. Read the article.
ADT May Increase Depression Risk in Prostate Cancer
When elderly men with localized prostate cancer are given androgen-deprivation therapy (ADT), the risk of depression and hospitalization for psychiatric treatment is significantly increased, a population-based study of 78,000 U.S. men showed. Read the article.
ADT May Increase Depression Risk in Prostate Cancer Read More »
Experimental urine test identifies 92% of men with elevated PSA levels
An experimental urine test that detects genetic changes associated with prostate cancer identified 92 percent of men with elevated PSA (prostate-specific antigen) levels who had high-grade cancers, according to a recent study. Read the article.
Experimental urine test identifies 92% of men with elevated PSA levels Read More »